Advertisement

Advertisement

CAMRF Stock Latest News

Camurus Expands Share Capital After Employee Stock Option Exercises

Company AnnouncementsCamurus Expands Share Capital After Employee Stock Option Exercises

Camurus Expands Share Capital After Employee Stock Option Exercises

PremiumCompany Announcements

Camurus Expands Share Capital After Employee Stock Option Exercises

1M ago

Camurus Strengthens Executive Team With New Corporate Development Chief

PremiumCompany Announcements

Camurus Strengthens Executive Team With New Corporate Development Chief

2M ago

Camurus AB Earnings Call: Growth, FX and U.S. Push

PremiumCompany Announcements

Camurus AB Earnings Call: Growth, FX and U.S. Push

2M ago

Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio

PremiumCompany Announcements

Camurus Posts Strong 2025 Earnings, Expands Long-Acting Endocrine Portfolio

2M ago

CAMRF Upcoming Earnings Report: What to Expect?

PremiumPre-EarningsCAMRF Upcoming Earnings Report: What to Expect?

2M ago

Camurus announces FDA acceptance of NDA resubmission for Oclaiz

The Fly

Camurus announces FDA acceptance of NDA resubmission for Oclaiz

3M ago

Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing

Company Announcements

Camurus’ acromegaly drug Oclaiz gains FDA review date after resubmitted US filing

3M ago

Camurus Increases Share Capital After Employee Stock Option Exercise

PremiumCompany Announcements

Camurus Increases Share Capital After Employee Stock Option Exercise

3M ago

Camurus Increases Shares and Votes Following Employee Stock Option Exercise

PremiumCompany Announcements

Camurus Increases Shares and Votes Following Employee Stock Option Exercise

4M ago

Camurus Announces Nomination Committee for AGM 2026

PremiumCompany Announcements

Camurus Announces Nomination Committee for AGM 2026

5M ago

Camurus AB Earnings Call: Growth Amid Challenges

PremiumCompany Announcements

Camurus AB Earnings Call: Growth Amid Challenges

5M ago

Camurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot

PremiumCompany AnnouncementsCamurus Reports Positive Phase 1b Results for Monthly Semaglutide Depot

5M ago

Camurus AB Reports Strong Q3 Growth Amid Revised Outlook

Company Announcements

Camurus AB Reports Strong Q3 Growth Amid Revised Outlook

5M ago

Camurus AB Reports Strong Q3 2025 Financial Performance and Strategic Milestones

Company Announcements

Camurus AB Reports Strong Q3 2025 Financial Performance and Strategic Milestones

5M ago

Camurus Increases Shares and Votes Following Employee Stock Option Exercise

PremiumCompany Announcements

Camurus Increases Shares and Votes Following Employee Stock Option Exercise

6M ago

Camurus AB Reports Strong Q2 2025 Financial Results

PremiumCompany Announcements

Camurus AB Reports Strong Q2 2025 Financial Results

9M ago

Camurus Reports Robust Growth in Q2 2025

PremiumCompany Announcements

Camurus Reports Robust Growth in Q2 2025

9M ago

Camurus AB (CAMRF) Q2 Earnings Cheat Sheet

PremiumPre-Earnings

Camurus AB (CAMRF) Q2 Earnings Cheat Sheet

9M ago

Camurus upgraded to Buy from Hold at DNB Carnegie

PremiumThe FlyCamurus upgraded to Buy from Hold at DNB Carnegie

9M ago

Camurus’ Oczyesa Gains EU Approval for Acromegaly Treatment

Company Announcements

Camurus’ Oczyesa Gains EU Approval for Acromegaly Treatment

9M ago

Camurus Expands Share Count to Support Employee Incentive Program

Company Announcements

Camurus Expands Share Count to Support Employee Incentive Program

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >